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Open access under CC BLead toxicity is long-recognised but continues to be a major public health problem. Its effects are wide-
ranging and include induction of hyper-anxiety states. In general it is thought to act by interfering with
Ca2+ signalling but speciﬁc targets are not clearly identiﬁed. Transient receptor potential canonical 5
(TRPC5) is a Ca2+-permeable ion channel that is linked positively to innate fear responses and unusual
amongst ion channels in being stimulated by trivalent lanthanides, which include gadolinium. Here we
show investigation of the effect of lead, which is a divalent ion (Pb2+). Intracellular Ca2+ and whole-cell
patch-clamp recordings were performed on HEK 293 cells conditionally over-expressing TRPC5 or other
TRP channels. Extracellular application of Pb2+ stimulated TRPC5 at concentrations greater than 1 lM.
Control cells without TRPC5 showed little or no response to Pb2+ and expression of other TRP channels
(TRPM2 or TRPM3) revealed partial inhibition by 10 lM Pb2+. The stimulatory effect on TRPC5 depended
on an extracellular residue (E543) near the ion pore: similar to gadolinium action, E543Q TRPC5 was
resistant to Pb2+ but showed normal stimulation by the receptor agonist sphingosine-1-phosphate. The
study shows that Pb2+ is a relatively potent stimulator of the TRPC5 channel, generating the hypothesis
that a function of the channel is to sense metal ion poisoning.
 2010 Elsevier Inc. Open access under CC BY license.Introduction
Lead (Pb2+) is a naturally occurring divalent cationic heavy me-
tal with high electronegativity and ﬂexible coordination number
that facilitates its interactions with oxygen and sulphur atoms of
proteins to form stable complexes [1]. It has no known physiolog-
ical function but is widely used in many commercial products. The
commonest sources of environmental Pb2+ are leaded gasoline,
food containers, toys, smelters, recycled batteries, paints, electron-
ics, water pipes and traditional medicines. The main route of entry
to the body is ingestion, particularly in children, and inhalation
through occupational exposure [2]. The toxic effects of Pb2+ depend
on the duration and magnitude of its exposure and also age and
nutritional status [3,4]. About 75–90% of absorbed Pb2+ is stored
in bones and teeth with the remainder in red blood cells and soft
tissues including liver [2].
Central nervous system defects presenting as developmental
abnormalities are themost common symptom in children. Although
Pb2+ can inﬂuence any part of the brain, it preferentially affects pre-
frontal cerebral cortex, cerebellumandhippocampus leading to cog-mbrane & Systems Biology,
iological Sciences, University
34 34228.
Y license.nitive defects, motor function and memory disturbances [3,5].
Anxiety states have been noted and animals exposed to Pb2+ exhib-
ited increased fear of aversive stimuli [6]. There are also other effects
on the body, including on the cardiovascular, renal and endocrine
systems [3]. Suggested mechanisms of action include induction of
oxidative stress and interference with Ca2+ and other signalling
pathways but the exact molecular targets for Pb2+ have not been
clearly established [3,7,8].
The mammalian transient receptor potential (TRP) family of cat-
ionic channels are widely expressed across many cell types [9–11].
One of the members of the Canonical subfamily is TRPC5, which is
a Ca2+ permeable channel that is stimulated by a range of factors
[12], which include lanthanide ions and protons [13,14]. Lantha-
nides appear to act relatively directly via a commonmechanism that
depends on amino acid residues (notably E543) in the outer pore
region of the channel [13,14].
An area of prominent TRPC5 expression is the mammalian
brain where speciﬁc neuronal functions are starting to emerge.
TRPC5 inhibits or potentiates neuronal growth cone formation
depending on the conditions [15–17] and mice lacking TRPC5 ex-
hibit diminished innate fear in response to aversive stimuli [18].
TRPC5 is also detected elsewhere, including in the cardiovascular
system where it contributes to heteromultimeric channel assem-
blies and has putative roles in development and remodelling
[19,20].
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other TRP channels (TRPM2 and TRPM3) which are also broadly ex-
pressed, including in neurones [21,22].Methods
Cell culture, plasmids, mutagenesis and transfection. Wild-type
and T-rex HEK 293 cells (Invitrogen) stably expressing human
TRPC5 [23], TRPM2 [24] or TRPM3 [25] under a tetracycline induc-
ible promoter were cultured in DMEM containing 10% foetal calf
serum, 100 U/ml penicillin and 100 lg/ml streptomycin. TRP chan-
nel expression in T-rex cells was induced by 1 lg/ml tetracycline
(tet+; Sigma) for 24–72 h before experimentation [23,25,26].
Non-induced cells cultured without addition of tetracycline (tet)
were controls. For transient transfection, human TRPC5 cDNAs was
cloned into pEGFPN1 and point mutations were introduced using
QuikChange site-directed mutagenesis (Stratagene) and appropri-
ate primer sets (forward (50–30): GCTTTACTTCTATTATCAAACCAG
AGCTATCGATG; reverse (50–30): CATCGATAGCTCTGGTTTGATAATA
GAAGTAAAGC). The mutation was conﬁrmed by direct sequencing
(University of Leeds DNA sequencing facility). cDNAs were tran-
siently transfected into wild-type HEK 293 cells with FuGENE 6
transfection reagent (Roche) 48 h prior to recording.
Intracellular Ca2+ measurement. HEK 293 cells were plated in 96-
well biocoat plates (Corning) at 60–70% conﬂuence 24 h before
experiments. Prior to recordings, cells were incubated for 1 h at
37 C in 2 lM fura-2AM dispersed in standard bath solution
(SBS) containing (mM): 140 NaCl, 5 KCl, 1.2 MgCl2, 1.5 CaCl2, 8 glu-
cose and 10 HEPES titrated to pH 7.4 using NaOH. The cells were
washed for 0.5 h in SBS and measurements were made on a 96-
well bench-top scanning ﬂuorimeter (FlexStation II) with SoftMax
Pro 4.7.1 (Molecular Devices, Sunnyvale, CA, USA) at room temper-
ature (21 ± 2 C). Fura-2 was excited with 340 and 380 nm light
and emission was collected at 510 nm. Intracellular Ca2+ was indi-
cated by the ratio of emission intensities for the two excitation
wavelengths.
Electrophysiology. Whole-cell patch-clamp recordings were per-
formed at room temperature as previously described [27]. Patch
pipette solution contained (mM): 115 CsCl, 2 MgCl2, 5 Na2ATP, 0.1
NaGTP, 10 HEPES, 10 EGTA and 5.7 CaCl2; ﬁnal pH was adjusted to
7.2 with CsOH. The extracellular solution was SBS. Signals were
ampliﬁed with an Axopatch 200B patch-clamp ampliﬁer and soft-
ware was Signal 3.05 (CED, UK). A ramp voltage protocol from
100 mV to +100 mV of 1 s in duration was applied every 10 s from
a holding potential of 0 mV. Current signals were ﬁltered at 1 kHz
and digitally sampled at 3 kHz. Patch pipettes had resistances of
3–5 MX.
Chemicals and reagents. All chemicals were from Sigma (UK) ex-
cept for fura-2AM (Invitrogen). One hundred millimolar stock solu-
tion of lead (II) nitrate (Pb(NO3)2) salt was prepared in water
freshly for each experiment.
Data analysis. Data sets were compared using Student’s t-tests
and expressed as mean ± SEM. Probability <0.05 (*) was considered
statistically signiﬁcant difference. All data are from at least three
independent experiments and single example results are represen-
tative of at least three independent experiments. ORIGIN software
was used for data analysis and presentation.Results
Pb2+ stimulates TRPC5 channels
The effect of Pb2+ was studied using whole-cell patch-clamp
applied to TRPC5-expressing (tet+) HEK 293 cells. As shown in
the representative time-series plot, external application of 10 lMPb2+ stimulated robust current in TRPC5 (tet+) cells that was inhib-
ited by the common TRPC channel blocker 2-aminoethoxydiphenyl
borate (2-APB; 75 lM; Fig. 1A). The current–voltage relationship
(I–V) of the current evoked by Pb2+ had the signature shape ex-
pected for TRPC5 channels (Fig. 1B cf. [13,23]). No current was
evoked by Pb2+ in control (tet) cells that were not over-express-
ing TRPC5 (Fig. 1C).
Pb2+ evoked Ca2+-entry was also detected in HEK 293 cells over-
expressing TRPC5 (Fig. 1D). Construction of a concentration–re-
sponse curve revealed a robust response at 2 lM Pb2+ (Fig. 1D
and E) and an EC50 of 5 lM (Fig. 1E). In control (tet) cells,
10 lM Pb2+ failed to evoke a Ca2+ signal but there were small re-
sponses to high concentrations of Pb2+ (Fig. 1E).
The data suggest that Pb2+ is a reasonably potent stimulator of
TRPC5 channels.
Stimulation depends on glutamate 543 (E543)
Conservative mutation of a glutamate residue (E543) to gluta-
mine (Q) in the predicted outer pore loop has been shown to abol-
ish lanthanide stimulation of TRPC5 channels [13]. This result was
conﬁrmed in HEK 293 cells transiently transfected with wild type
TRPC5 or E543Q mutant TRPC5 in whole-cell patch-clamp experi-
ments (Fig. 2A and B). The E543Q TRPC5 channels were success-
fully expressed and functional because they could be stimulated
by sphingosine-1-phosphate (S1P) (Fig. 2B), which acts via a differ-
ent mechanism [19].
We therefore investigated whether stimulation of TRPC5 by
Pb2+ might also depend on E543. Cells expressing E543Q TRPC5
were strikingly insensitive to Pb2+ yet responded robustly to S1P
(Fig. 2C and D) with the characteristic TRPC5 I-V (Fig. 2E).
The data suggest that stimulation of TRPC5 by Pb2+ depends on
the negative charge of glutamate 543 and therefore has a mecha-
nism of action that is shared by lanthanides.
Inhibition of other types of TRP channel
For comparison, Pb2+ was tested against other types of TRP
channel for which we have generated the same type of conditional
expression system.
Hydrogen peroxide (H2O2) is a stimulator of TRPM2 channels
[24] and was used to evoke TRPM2 activity in Ca2+ measurement
assays. H2O2 but not Pb2+ (10 lM) evoked Ca2+ inﬂux in induced
TRPM2 (tet+) cells (Fig. 3A). The potential for an inhibitory effect
of Pb2+ was evaluated by pre-incubating TRPM2 cells (tet+) with
10 lM Pb2+ and then measuring Ca2+ inﬂux in response to H2O2.
There was an inhibitory effect of Pb2+ (Fig. 3B and C).
Pregnenolone sulphate (PregS) is a stimulator of TRPM3 chan-
nels [28] and was used to evoke TRPM3 activity in Ca2+ measure-
ment assays. PregS but not Pb2+ (10 lM) evoked Ca2+ inﬂux in
induced TRPM3 (tet+) cells (Fig. 3D). The potential for an inhibitory
effect of Pb2+ was evaluated by pre-incubating TRPM3 cells (tet+)
with 10 lM Pb2+ and then measuring Ca2+ inﬂux in response to
PregS. There was an inhibitory effect of Pb2+ (Fig. 3E and F).
The data suggest that Pb2+ is not speciﬁc for TRPC5 because it
also affected other TRP channels (i.e. TRPM2 and TRPM3). How-
ever, the other TRP channels were inhibited rather than stimulated
by Pb2+.Discussion
The study shows that low micromolar concentrations of Pb2+
stimulate TRPC5 channels via a mechanism that depends on a neg-
atively-charged amino acid in the third extracellular loop of TRPC5.
To our knowledge it is the ﬁrst report of the molecular identity of a
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TRP channel sensitivity to Pb2+. The study raises the possibility that
TRPC5 senses toxic actions of Pb2+ that are relevant to public
health. We speculate that the pro-anxiety role of TRPC5 is relevant
to this context and suggest the hypothesis that the unusual metal
ion sensitivity of TRPC5 has evolved as an early detection system
for metal ion poisoning.
TRPC5 is stimulated by La3+ or Gd3+ acting in a similar concen-
tration range to Pb2+ [13]. Ca2+ is able to mimic the effect but only
at concentrations at least 1000 times higher [23]. Potential phys-
ico-chemical requirements for the effect include atomic radii and
electron afﬁnities which are similar for La3+, Gd3+ and Pb2+ but
not Ca2+. Putatively, the channel contains a toxic metal ion accep-
tor site around E543 in the turret region of the outer ion pore ves-
tibule; binding of a suitable ion leading to a conformational change
that stabilises the channel open state. Mild acidiﬁcation partially
mimics the effect [14] and a similar effect arises through breaking
of a disulphide bridge close to E543, an effect that is relevant to
inﬂammatory conditions [27]. The ﬁndings support the hypothesis
that the capacity of TRPC5 to be stimulated by agents acting at its
turret is a crucial aspect of its function in mammalian biology. Only
TRPC4 shares this property. Although a metal ion binding site in
the outer vestibule of TRPC5 is an attractive hypothesis it is not
possible to exclude other mechanisms of action of Pb2+ and lantha-
nides because the charge on these ions disturbs the lipid bilayer
and the ions may be able to enter cells through cation channels.
If the ions act indirectly through the bilayer or via an intracellular
site, however, the E543 residue must still be a crucial element in
the coupling mechanism to channel opening.
According to the U.S. Centers for Disease Control, maximum
permissible blood lead level (BLL) is 0.5 lM in children and 1 lMin adults. Although BLL rarely goes above 1 lM in non-high risk
populations, in the organs like bone, teeth, liver and brain where
Pb2+ is accumulated and stored there may be exposure to much
higher levels [3,4]. It has been common to detect BLL of more than
2.5 lM in workers with occupational Pb2+ exposure [4]. These con-
centrations are in exactly the right range for TRPC5 to act as a sen-
sor. Although Pb2+ toxicity exhibits broad-ranging symptoms, a
feature is hyper-anxiety and stress [6]. It is, therefore, important
to consider that TRPC5 is expressed in the fear centre of the amyg-
dala and that TRPC5 knock-out mice exhibit diminished fear [18]. It
seems probable therefore that Pb2+ accumulation in the brain en-
hances TRPC5 activity in the amygdala, raising sensation of fear.
Analogous is the suggestion that acidiﬁcation in the amygdala links
carbon dioxide accumulation to fear [29]. In both cases TRPC5 has
properties and expression that would enable it to play a key role,
but direct testing of these hypotheses is awaited. It would be mis-
leading to suggest that Pb2+ has speciﬁcity for TRPC5 but sensitiv-
ity of the channel to Pb2+ concentrations just above the BLL and the
channel’s apparently pronounced role in responses to aversive
stimuli (at least in mice) leads us to suggest the novel hypothesis
that TRPC5 has conferred evolutionary advantage as a sensor of
poisonous metal ions in the environment.
In summary, the data show that TRPC5 channels can be acutely
stimulated by concentrations of Pb2+ that are relevant to public
health. The molecular mechanism mediating the effect appears
similar to that underlying previously reported stimulatory effects
of lanthanides on TRPC5, requiring an amino acid residue in the
predicted outer vestibule of the channel. Taken together with re-
cent evidence for a role of TRPC5 in fear responses we speculate
that Pb2+ sensing by TRPC5 may confer a survival advantage by
generating a sense of aversion.
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